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Abstract
Dietary intervention may alter the insulin-like growth factor (IGF) system and thereby cancer risk. In a qualitative review, eleven of twenty studies showed a
link between one or more carotenoids, vegetable or fruit intake and the IGF system, however, with partly contrary ﬁndings, such that no ﬁrm conclusion
can be drawn. Therefore, we evaluated associations between serum carotenoid concentrations or the intake of fruits and vegetables with IGF-1, IGF bind-
ing protein (BP)-3 and their molar ratio (IGF-1:IGFBP-3) within the Third National Health and Nutrition Examination Survey (NHANES III, 1988–
1994). In our analysis, we included 6061 NHANES III participants and used multivariable-adjusted linear regression models. IGF-1 concentrations
were signiﬁcantly positively associated with serum concentrations of lycopene, β-carotene, α-carotene, β-cryptoxanthin and lutein/zeaxanthin in men
and women. Statistically signiﬁcant positive associations were observed for serum concentrations of α-carotene and lutein/zeaxanthin and intake of fruits
with serum IGFBP-3 concentrations in women, but not in men. The IGF-1:IGFBP-3 molar ratio was signiﬁcantly positively associated with serum con-
centrations of lycopene, β-carotene and α-carotene in men and with β-carotene in women. In conclusion, dietary interventions with carotenoids, fruits and
vegetables may affect the IGF system, although the direction of these effects is currently unclear.
Key words: Carotenoids: Insulin-like growth factor-1: Insulin-like growth factor binding protein-3: Third National Health and Nutrition
Examination Survey
The primary role of the human growth hormone insulin-like
growth factor (IGF) axis is the regulation of both prenatal
and postnatal growth(1,2), and IGF binding proteins (IGFBP)
are essential modulators of the biological actions of IGF(3).
Besides the regulation of normal growth and ageing, the
IGF system is also involved in carcinogenesis(4). Circulating
concentrations of IGF system components are determined
by both genetic factors (40–60 %, polymorphisms, imprinting)
as well as dietary and lifestyle factors (e.g. diet, smoking, phys-
ical activity and others)(5).
Carotenoids, such as α-carotene, β-carotene and
β-cryptoxanthin, are known as provitamin A(6). Dietary
β-carotene is present at relatively high concentrations in carrots
and yellow and green leafy vegetables; α-carotene is present in
carrots and red palm oil; and β-cryptoxanthin is found in sweet
red pepper, oranges, tangerines and papaya(7). Six species of
carotenoids comprise about 60–70 % of the total carotenoid
pool in human plasma(8,9). The potential of carotenoids to
modulate immune responses has been demonstrated in vivo
and in cell models(10). Besides their antioxidant activity(11),
investigators have proposed that carotenoids affect cell–cell
communications(12) and have effects on membrane structure
and signal transduction pathways(10). Large numbers of epi-
demiological studies have explored a possible association
Abbreviations: IGF, insulin-like growth factor; IGFBP, insulin-like growth factor binding protein; NHANES III, Third National Health and Nutrition Examination Survey.
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between carotenoid intake and reduced risk of CVD and can-
cer(13–18), such as breast cancer(19), nasopharyngeal carcin-
oma(20) or urothelial cell carcinoma(21,22).
Lycopene, an acyclic non-provitamin A carotene, has
received considerable attention for its possible role in cancer
prevention, especially prostate cancer(23–25). Lycopene is a
tomato-derived substance, but is also present in watermelon,
pink grapefruit, guava, papaya and apricots(26) and accounts
for about 50 % of the carotenoids found in human blood;
thus, it is the predominant carotenoid. It is a natural fat-soluble
pigment and the most potent singlet oxygen quencher and free
radical scavenger among all natural carotenoids(27). Therefore,
lycopene is thought to decrease cancer risk through a reduc-
tion in oxidative damage(28). In animal models, effects of lyco-
pene on the endocrine IGF system, i.e. increased serum
IGFBP-3 and decreased serum IGF-1:IGFBP-3 ratio, have
been described(29). Lycopene may inhibit activation of the
IGF-1 receptor(30), alter IGF-1-stimulated cell proliferation
in vitro(30,31), induce cell cycle arrest(26,28), modulate intercellu-
lar communication via gap junction mechanisms(32,33), and
have strong provitamin A activity via RAR-retinoid-X recep-
tors (RXR) signalling pathways(34–36).
Based on the observations that both carotenoids and com-
ponents of the IGF system have been found to be associated
with cancer risk in some studies and potential associations
between lycopene, as the most abundant carotenoid, and the
IGF system in in vitro and in vivo studies, it was the aim of
our study to examine the associations between circulating
levels of carotenoids and fruit and vegetable consumption
and serum concentrations of IGF-1, IGFBP-3 and their
molar ratio in a cross-sectional US study.
Methods
Study population and data collection
The Third National Health and Nutrition Examination Survey
(NHANES III) is a nationally representative sample of
civilian non-institutionalised individuals conducted by the
National Center for Health Statistics of the Centers for
Disease Control and Prevention from 1988 to 1994(37). This
cross-sectional study was designed to collect the health and
nutrition information of Americans aged 2 months and
older through a structured household interview, serum collec-
tion and a physical examination in a mobile examination
centre. In NHANES III, 39 695 persons were recruited(37).
The protocols for the conduct of NHANES III were
approved by the Institutional Review Board of the National
Center for Health Statistics, US Centers for Disease Control
and Prevention. Informed consent was obtained from all
participants.
In NHANES III, a FFQ over a 1-month reference period
was to assess habitual diet, and we computed total fruit
(four food items) and total vegetable (eleven food items) con-
sumption based on the FFQ information. However, since only
consumption frequency, but not portion sizes, has been
assessed, we were not able to adjust for energy, macro- or
micronutrient intake in our analysis.
Ascertainment of carotenoids, insulin-like growth factor-1 and
insulin-like growth factor binding protein-3
Serum concentrations of α-carotene, β-carotene, β-cryptox-
anthin, lycopene and lutein/zeaxanthin were determined
using isocratic HPLC-based methods with detection at three
different wavelengths (300, 325 and 450 nm; Waters HPLC
System). Because these methods do not discriminate lutein
from zeaxanthin, the combined concentration of lutein and
zeaxanthin is used in analyses. Median interassay CV were
9·4 % for α-carotene, 7·0 % for β-carotene, 8·7 % for
β-cryptoxanthin, 7·7 % for lycopene and 11·0 % for lutein/
zeaxanthin(38). IGF-1 and IGFBP-3 concentrations were
assessed in serum samples of NHANES III participants,
20+ years old (n 6061) from the NHANES III study popula-
tion, who had participated in a morning examination(39).
Individuals who participated in the morning session provided
a blood sample after a mean overnight fast of approximately
11 h. Serum IGF-1 concentrations were available for 2742
men and 3316 women. Three persons were excluded with
missing data. Serum samples were sent to the Diagnostic
Systems Laboratories (DSL) in Webster, TX, which used the
IGF-1 enzyme-linked immunosorbent assay (DSL 10-5600)
and the IGFBP-3 immunoradiometric assay (DSL 6600) to
measure serum concentrations of these biomarkers. Data for
storage history and quality control for the 6061 serum samples
from NHANES III have been reported in another study(39).
The molar ratio of IGF-1:IGFBP-3 was computed as an indi-
cator of free IGF-1 concentration(40).
Statistical analysis
For the characterisation of the study population, medians and
interquartile ranges of all continuous parameters and percen-
tages of all categorical parameters by sex were computed.
Linear regression was used to examine the associations of
fruit and vegetable consumption and serum concentrations
of carotenoids (independent variables) with serum concen-
tration of IGF-1, IGFBP-3 and their molar ratio (IGF-1:
IGFBP-3) (dependent variables). Because serum carotenoid
concentrations were not normally distributed in the study
population, these values were transformed using the natural
logarithm. Thus, we computed geometric mean concentrations
of carotenoids by quintiles of IGF-1 and IGFBP-3, separately
for men and women. We decided to stratify by sex a priori
because IGF-1 and IGFBP-3 concentrations differ between
men and women. For fruit and vegetable consumption,
which were normally distributed, we computed arithmetic
means by sex. In the linear regression models, we controlled
for age (continuous), race/ethnicity (non-Hispanic white,
non-Hispanic black, Mexican American, other), smoking sta-
tus (current, former or never smoker), alcohol consumption
(non-consumer, up to once per week, less than daily but
more than once/week, at least once per d), BMI (continuous)
and serum cholesterol concentration (continuous). These vari-
ables were chosen a priori based on a literature review. Trend
tests were performed by assigning to each individual the
value 1 to 5 for the concentration/consumption category
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(1–5) into which the subject fell. We modelled this term as a
continuous variable and the coefﬁcient was evaluated by the
Wald test. All tests were two-sided; P values <0·05 were con-
sidered to be statistically signiﬁcant.
All statistical analyses were performed using SUDAAN(41)
as implemented in SAS v. 9.1 (SAS Institute) software and
weighted to take into account over-sampling, refusal, selection
probabilities and differences from the general US popula-
tion(37). The protocols for the conduct of NHANES III
were approved by the Institutional Review Board of the
National Center for Health Statistics, US Centers for
Disease Control and Prevention. Informed consent was
obtained for all participants(25).
Results
Of the 2742 men included in this analysis, 77·6 % were
non-Hispanic white, 9·5 % non-Hispanic black and 5·3 %
Mexican-American; of the 3316 women, 76·5 % were
non-Hispanic white, 11·3 % non-Hispanic black and 4·8 %
Mexican-American. Table 1 shows baseline characteristics of
study participants and the baseline median concentrations of
carotenoids, IGF-1 and IGFBP-3. Men were younger and
had higher BMI than women. Men were more likely to be cur-
rent smokers and current drinkers of alcohol than women.
Serum concentrations of all carotenoids but serum lycopene
tended to be higher in women than in men. Serum IGF-1 con-
centrations tended to be higher and IGFBP-3 lower in men
than in women.
In both sexes, serum IGF-1 and IGFBP-3 concentrations
increased with increasing serum concentrations of all carote-
noids (Table 2). Statistically signiﬁcantly positive associations
were observed for serum concentrations of lycopene,
β-carotene, α-carotene, β-cryptoxanthin and lutein/zeaxanthin
with IGF-1 in both men and women (all P trend <0·05).
Overall, the increase in IGF-1 across quintiles of β-carotene,
α-carotene and lutein/zeaxanthin was more pronounced
among women than among men, whereas the increase in
IGF-1 across quintiles of lycopene and β-cryptoxanthin was
more pronounced among men.
Statistically signiﬁcantly positive associations between serum
concentrations of α-carotene and lutein/zeaxanthin with
IGFBP-3 were observed in women (all P trend <0·05), but
not in men. IGFBP-3 concentrations in men and women
tended to increase with increasing lycopene, β-carotene and
β-cryptoxanthin concentrations, but test for trend was not stat-
istically signiﬁcant (all P trend <0·05).
The IGF-1:IGFBP-3 molar ratio showed statistically signiﬁ-
cant positive associations with serum concentrations of lyco-
pene, β-carotene and α-carotene in men, but no associations
were observed for β-cryptoxanthin and lutein/zeaxanthin. In
women, we only observed an association of the IGF-1:
IGFBP-3 ratio with β-carotene concentration.
Only fruit intake was signiﬁcantly positively associated with
IGFBP-3 concentrations in women, and there was no signiﬁ-
cant association in men. Results for IGF-1 concentrations or
the IGF-1:IGFBP-3 molar ratio were non-signiﬁcant in both
sexes. The analyses of the association of IGF-1, IGFBP-3
or the IGF-1:IGFBP-3 molar ratio with intake of vegetables
did not show any statistically signiﬁcant ﬁnding in women or
men (all P trend >0·05).
Discussion
Our study was driven by the observation from animal and cell
models that carotenoids, in particular lycopene, might beneﬁ-
cially inﬂuence components of the IGF system(29). Prior to our
analysis, twenty epidemiological studies had been published
since 1999 that examined possible associations of carotenoid
intake or circulating carotenoid concentrations, and consump-
tion of fruits and vegetables with circulating concentrations of
Table 1. Baseline characteristics of study participants in the Third
National Health and Nutrition Examination Survey (NHANES III) by sex
(Percentages, medians and interquartile ranges or mean values and 95
% confidence intervals)
Variables Men (%) Women (%)
Sex 46·6 53·4
Race/ethnicity
Non-Hispanic white 77·6 76·5
Non-Hispanic black 9·5 11·3
Mexican-American 5·3 4·8
Other 7·6 7·4
Alcohol consumption
Never 35·4 51·9
Up to once/week 18·0 21·3
Less than daily but
more than once/week
31·5 21·1
Daily 15·1 5·7
Smoking status
Never smoker 36·6 54·6
Former smoker 33·2 21·3
Current smoker 30·2 24·1
Age (years)
Median 39·8 40·8
Interquartile range 29·4–54·2 30·3–56·7
BMI (kg/m2)
Median 25·9 25·1
Interquartile range 23·5–29·2 21·8–29·7
Serum lycopene (μmol/l)
Geometric mean 0·40 0·37
95 % CI 0·38, 0·41 0·36, 0·38
Serum β-carotene (μmol/l)
Geometric mean 0·23 0·32
95 % CI 0·22, 0·24 0·30, 0·33
Serum α-carotene (μmol/l)
Geometric mean 0·05 0·07
95 % CI 0·05, 0·06 0·06, 0·07
Serum β-cryptoxanthin (μmol/l)
Geometric mean 0·12 0·14
95 % CI 0·12, 0·13 0·13, 0·14
Serum lutein/zeaxanthin (μmol/l)
Geometric mean 0·34 0·34
95 % CI 0·32, 0·35 0·33, 0·35
Serum cholesterol (mmol/l)
Geometric mean 5·12 5·16
95 % CI 5·07, 5·17 5·11, 5·21
IGF-1 (ng/ml)
Geometric mean 265 236
95 % CI 260, 271 229, 243
IGFBP-3 (μg/g)
Geometric mean 4250 4431
95 % CI 4179, 4322 4365, 4497
IGF, insulin-like growth factor; IGFBP, insulin-like growth factor binding protein.
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Table 2. Comparison of serum insulin-like growth factor-1 (IGF-1; ng/ml), serum insulin-like growth factor binding protein-3 (IGFBP-3; μg/g) concentrations and their molar ratio according to categories of serum
concentrations of carotenoids and total fruit and vegetable intake among men and women (Geometric means and 95 % confidence intervals)
IGF-1 (ng/ml) IGFBP-3 (μg/g) IGF-1:IGFBP-3 ratio
Men Women Men Women Men Women
Geometric mean* 95 % CI Geometric mean 95 % CI Geometric mean 95 % CI Geometric mean 95 % CI Geometric mean 95 % CI Geometric mean 95 % CI
Carotenoids
Lycopene†
Q1 254 239, 270 230 216, 245 4113 3951, 4283 4385 4262, 4511 0·22 0·21, 0·23 0·19 0·18, 0·20
Q2 262 251, 273 218 198, 241 4329 4197, 4466 4315 4185, 4449 0·22 0·21, 0·23 0·18 0·17, 0·20
Q3 268 256, 280 234 225, 243 4342 4238, 4448 4430 4325, 4538 0·22 0·21, 0·23 0·19 0·18, 0·20
Q4 262 253, 272 238 227, 249 4250 4127, 4376 4497 4402, 4594 0·22 0·22, 0·23 0·19 0·18, 0·20
Q5 282 273, 292 245 237, 253 4295 4180, 4412 4449 4342, 4560 0·24 0·23, 0·25 0·20 0·19, 0·21
P trend 0·01 0·02 0·35 0·07 0·01 0·06
β-Carotene†
Q1 252 241, 263 204 180, 232 4289 4150, 4431 4326 4171, 4487 0·21 0·20, 0·22 0·17 0·15, 0·19
Q2 263 254, 272 230 219, 241 4264 4166, 4365 4404 4296, 4515 0·22 0·22, 0·23 0·19 0·18, 0·20
Q3 265 256, 275 234 223, 245 4216 4100, 4335 4401 4285, 4520 0·23 0·22, 0·24 0·19 0·18, 0·20
Q4 274 263, 286 239 227, 252 4288 4171, 4409 4466 4379, 4556 0·23 0·22, 0·24 0·19 0·19, 0·20
Q5 284 273, 295 258 249, 268 4316 4202, 4434 4494 4383, 4608 0·24 0·23, 0·25 0·21 0·20, 0·22
P trend <0·01 <0·01 0·70 0·10 <0·01 0·01
α-Carotene†
Q1 256 248, 265 209 186, 235 4209 4108, 4311 4252 4150, 4357 0·22 0·21, 0·23 0·18 0·16, 0·20
Q2 267 256, 279 236 225, 246 4251 4093, 4416 4394 4303, 4487 0·23 0·22, 0·24 0·19 0·19, 0·20
Q3 264 251, 278 226 217, 235 4356 4183, 4535 4334 4201, 4471 0·22 0·21, 0·23 0·19 0·18, 0·20
Q4 267 255, 279 244 232, 256 4216 4116, 4319 4516 4413, 4620 0·23 0·22, 0·24 0·20 0·19, 0·20
Q5 284 271, 298 247 234, 261 4363 4212, 4520 4538 4414, 4666 0·24 0·23, 0·25 0·20 0·19, 0·21
P trend 0·01 0·04 0·20 <0·01 0·01 0·19
β-Cryptoxanthin†
Q1 257 248, 267 218 201, 237 4154 4055, 4256 4331 4226, 4439 0·22 0·22, 0·23 0·18 0·17, 0·20
Q2 267 258, 276 237 228, 246 4308 4208, 4411 4451 4365, 4538 0·22 0·22, 0·23 0·19 0·18, 0·20
Q3 267 258, 277 243 234, 253 4255 4125, 4389 4452 4347, 4558 0·23 0·22, 0·23 0·20 0·19, 0·21
Q4 262 250, 274 235 223, 248 4271 4161, 4385 4451 4302, 4606 0·22 0·21, 0·23 0·19 0·18, 0·20
Q5 292 281, 304 247 234, 262 4400 4256, 4549 4477 4329, 4629 0·24 0·23, 0·25 0·20 0·19, 0·21
P trend <0·01 0·04 0·06 0·14 0·05 0·07
Lutein/zeaxanthin†
Q1 257 245, 269 214 196, 233 4166 4055, 4281 4234 4126, 4345 0·22 0·21, 0·23 0·18 0·17, 0·20
Q2 265 255, 275 233 222, 244 4307 4180, 4437 4402 4290, 4518 0·22 0·21, 0·23 0·19 0·18, 0·20
Q3 273 263, 285 245 235, 256 4274 4180, 4370 4521 4412, 4633 0·23 0·22, 0·24 0·20 0·19, 0·20
Q4 265 252, 279 236 223, 250 4268 4122, 4418 4428 4303, 4557 0·22 0·22, 0·23 0·19 0·18, 0·20
Q5 281 269, 295 244 234, 255 4347 4232, 4465 4540 4419, 4665 0·23 0·23, 0·24 0·19 0·19, 0·20
P trend 0·01 0·02 0·10 <0·01 0·07 0·22
Vegetables†
Q1 261 251, 271 222 204, 242 4186 4052, 4323 4293 4192, 4397 0·22 0·21, 0·23 0·18 0·17, 0·20
Q2 271 262, 280 237 227, 248 4254 4150, 4362 4372 4255, 4492 0·23 0·22, 0·23 0·19 0·19, 0·20
Q3 261 250, 272 242 232, 252 4305 4186, 4428 4552 4461, 4645 0·21 0·21, 0·22 0·19 0·18, 0·19
Q4 273 258, 289 229 218, 240 4310 4171, 4453 4388 4270, 4510 0·22 0·22, 0·23 0·18 0·17, 0·19
Q5 273 261, 285 241 227, 256 4293 4175, 4415 4501 4392, 4612 0·23 0·22, 0·23 0·19 0·18, 0·20
P trend 0·12 0·05 0·15 0·80 0·60 0·79
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IGF-1 and IGFBP-3 (Supplementary Table S1). Of the twenty
studies, eleven showed a link between one or more carote-
noids, vegetables or fruits and the IGF system with either a
positive or negative association. However, the results, as dis-
cussed below, were not consistent for carotenoid subgroups
or nutrients and partly contradictory.
Associations with insulin-like growth factor-1
In the NHANES III analysis, higher serum concentrations of
carotenoids were associated with higher IGF-1. This is in con-
trast to the theory that high carotenoid concentrations may
protect from cancer by decreasing circulating levels of
IGF-1. Our positive associations of serum lycopene concen-
trations with IGF-1 concentrations in men and women con-
trast with three other studies (case–control or intervention
study), which found an inverse relationship between lycopene
(supplement use or serum level) and IGF-1 concentra-
tions(42–44) and thirteen studies that did not ﬁnd any associ-
ation (see Supplementary Table S1). All three studies with
inverse associations had a very small number of participants
ranging from twenty to 112 individuals and the two interven-
tion studies(43,44) had very short treatment duration of 10–26
d. The positive association between serum lycopene concen-
trations and IGF-1 concentrations in our analysis might be
due to differences in adjustment(42,44) or the selection of
study participants(43).
The results of our analysis are in part consistent with those
of Suzuki et al.(6), who observed signiﬁcantly higher serum
α-carotene, β-carotene and β-cryptoxanthin with increasing
serum IGF-1 concentrations among women, but not men of
a Japanese observational study. Our ﬁndings for associations
with IGF-1 concentrations did not differ by sex. In contrast
to our result and that of Suzuki et al.(6), one epidemiological
study showed that serum β-carotene concentrations were
inversely related to IGF-1 concentrations(45). In addition,
positive associations with serum IGF-1 concentrations
were found for carotene(46), α-carotene(6,47), β-carotene(6), β-
cryptoxanthin(6,48) and for fruit intake(46), but most other stud-
ies (n 12; Supplementary Table S1) showed no association with
any carotenoid, fruit or vegetable intake and IGF-1.
Associations with insulin-like growth factor binding protein-3
Positive associations with IGFBP-3 concentrations were
found for lycopene(48,49), vegetables(50) and fruits(46), which
is in line with the observation that higher IGFBP-3 concentra-
tions were related to decreased risk of several cancers(51–53). In
contrast, an inverse relationship with serum IGFBP-3 concen-
trations was reported in two case–control studies for lycopene,
lutein/zeaxanthin(6) and for vegetable intake(46). The majority
of studies (n 12), though, showed no association of any carot-
enoid examined with IGFBP-3 (Supplementary Table S1). The
positive relationships of serum α-carotene and lutein/zeax-
anthin concentrations with IGFBP-3 concentrations observed
in our analysis in woman are new and in contrast to Suzuki
et al.(6), who found an inverse relationship of serum lutein/
zeaxanthin concentrations with IGFBP-3 in men. It shouldFr
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be kept in mind that α-carotene concentrations in serum are
generally very low and rather variable(54); thus it cannot be
excluded that the observed association is due to chance. Our
results are in line with nine studies that reported no signiﬁcant
associations between lycopene and IGFBP-3 (Supplementary
Table S1), although also inverse(6) and positive associa-
tions(48,49) have been reported.
Associations with the molar ratio (insulin-like growth factor-1:
insulin-like growth factor binding protein-3)
In epidemiological studies, the IGF-1:IGFBP-3 molar ratio
has been used as an approximate index of ‘free’, bioactive
IGF-1, since IGFBP-3 is the main binding protein of IGF-1
in the circulation(40,51–53). However, the biological effects of
the different IGFBP on IGF-1 bioactivity are still relatively
unknown. Similar to IGFBP-3, IGFBP-1 and -2 may also
reduce bioactive IGF-1 by binding to it and making it unavail-
able for the IGF-1 receptor. On the other hand, IGFBP-1 and
-2 allow the transport of IGF-1 out of the bloodstream, which
may result in increased IGF-1 concentrations at the tissue
level(55).
In our analysis, higher molar ratios of IGF-1:IGFBP-3 were
related to higher serum concentrations of lycopene, β-carotene
and α-carotene in men and to higher β-carotene concentration
in women. These ﬁndings are in contrast to four other stud-
ies(42–44,56) that showed an inverse relationship between lyco-
pene intake or serum concentrations to the molar ratio
IGF-1:IGFBP-3; three studies showed no association with
the molar ratio (Supplementary Table S1). NHANES III is
the ﬁrst study that examined the molar ratio and its associa-
tions with serum concentrations of β-carotene and α-carotene.
Methodological considerations
This summary of study results shows that a diet rich in caro-
tenoids, vegetables and fruits may inﬂuence the IGF system
and indirectly cancer risk, but the results were diverse. Study
design, study population, and use of circulating concentration
of carotenoids or dietary intake may inﬂuence the results of a
study.
Seven of these previous twenty studies were intervention
studies; all others were cross-sectional studies. Intervention
studies are considered to provide the most reliable evidence
in epidemiological research(57). However, results of the inter-
vention studies did not differ from cross-sectional studies
(see Supplementary Table S1).
The majority of studies were conducted in Europe and in
the USA; only a few were conducted in Japan and in Israel.
In a Japanese study(6,46) both IGF-1 and IGFBP-3 concentra-
tions were positively associated with fruit consumption(44); in a
second Japanese study(10) lutein/zeaxanthin and IGFBP-3
were inversely associated, and there were no signiﬁcant results
in studies from Europe or the USA. For other carotenoid sub-
groups and vegetables, we found no differences between
European, Asian or US studies.
Of the twenty studies reviewed above, most assessed nutri-
ent intake by FFQ, whereas eight studies measured carotenoid
concentration in blood samples. Studies that assessed
dietary lycopene intake had similarly inconsistent results as
studies that examined circulating lycopene (Supplementary
Table S1). Although several studies reported no associations
of IGF-1 or IGFBP-3 with either dietary intake or circulating
carotenoids (Supplementary Table S1), positive associations
with IGF-1 were found for intake of carotenoids(46) and
α-carotene(47) as well as α- and β-carotene concentration(6).
Negative associations with IGF-1 were found for intake of
β-carotene(45). One study reported an inverse association
with IGFBP-3 for lutein/zeaxanthin concentration(6). In con-
clusion, it appears that the assessment methodology, i.e., meas-
urement of circulating concentrations or dietary intake
assessment, has an impact on the results of a study. To further
investigate this potential difference, future studies with both
measurement methodologies and comparison of the results
will help to elucidate these associations.
Individuals who try to eat a healthy diet, such as high in
fruits, vegetables or ﬁsh, but low in red meat, sugar or
salt(58), are likely to lead a healthy lifestyle in general. The
inability to distinguish the effect of diet from that of other life-
style factors may pose a threat to the validity of diet–disease
associations observed in epidemiological studies(59). It has
been suggested that carotenoids could act as surrogate markers
of a diet high in fruits and vegetables(60), given that high circu-
lating levels are indeed due to high fruit and vegetable con-
sumption rather than supplement intake. Therefore, we
investigated the impact of intake of vegetables and fruits on
the IGF system in this study as well. Previously, three stud-
ies(45,46,56) observed an inverse relationship between vegetable
intake and IGF-1, IGFBP-3 and their molar ratio, whereas a
fourth(50) showed positive associations for vegetable intake
and IGFBP-3 in African-Americans. The results of
NHANES III do not support any of these ﬁndings. None
of our results for vegetable intake was statistically signiﬁcant,
which is consistent with several other studies (Supplementary
Table S1). In contrast to vegetables, fruit intake had a positive
association with serum concentrations of IGFBP-3 in women
in our analysis. Our ﬁndings for the intake of fruits are consist-
ent with those of Maruyama et al.(46), but in contrast to us, they
additionally showed positive associations with serum concen-
trations of IGF-1. Based on the observation that only few
associations with the intake of vegetables and fruits but
more with the intake of carotenoids were observed, one
might conclude that carotenoids do not merely act as surrogate
markers of a generally healthy lifestyle. To eliminate confound-
ing, we adjusted for age, race/ethnicity, BMI, cigarette smok-
ing, alcohol consumption and serum total cholesterol
concentration.
Strengths and limitations
The study population is a strength of this study as it is based
on a large, nationally representative sample of the US popula-
tion, and therefore the results have greater external validity
than studies of more selected populations(61). The composition
and size of the study population provided us with the oppor-
tunity to stratify our analyses by sex. We were able to conﬁrm
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prior observations regarding the relationship between some
carotenoids and the IGF system and showed some new asso-
ciations especially for lycopene. Diet had been assessed for a
4-week period prior to the interview. Differences in fruit
and vegetable availability changes due to seasonality might
have affected circulating carotenoids. Degradation of stored
samples can be problematic in studies, in which these samples
have long, complex storage histories. IGF-1 and IGFBP-3
were measured 10–16 years after the blood samples were
obtained(40). A study by Yu et al.(62) has, however, shown
that IGF-1 and IGFBP-3 appear to be stable in response to
multiple freeze–thaw cycles. A further limitation of this
study is that it is cross-sectional and that our results are
based on total circulating IGF-1 levels instead of free
IGF-1. Finally, we performed a large number of statistical
tests and cannot exclude that some of our ﬁnding are simply
due to chance.
In conclusion, this analysis further supports that the IGF
system, with potential inﬂuence on several cancers, may be
modiﬁed through nutrition, especially carotenoids. In
NHANES III, positive relationships between serum concen-
trations of lycopene, β-carotene, α-carotene, β-cryptoxanthin
and lutein/zeaxanthin to IGF-1 concentrations were observed,
which is, however, in contrast to the expected inverse associa-
tions. The positive associations observed for serum α-carotene
and lutein/zeaxanthin concentrations and intake of fruits in
relation to IGFBP-3 concentrations are more in line with cur-
rent thinking of the biological mechanism. Based on ours and
the observations of other studies, one might conclude that car-
otenoids may contribute to IGF-1 and IGFBP-3 modulation,
but this very likely depends on the presence of other factors,
many of which are still unrevealed or unknown. Clearly, the
results deserve conﬁrmation by further larger studies, for
example by intervention study to evaluate whether increased
consumption of carotenoid-rich fruits and vegetables is able
to modulate circulating levels of components of the IGF
system.
Supplementary material
The supplementary material for this article can be found at
http://www.journals.cambridge.org/10.1017/jns.2016.1
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